Your DNA has a story to tell. A story about your past, present, and future health
Join UJA Healthcare, CommUnity, and UJA Young Leaders for a panel discussion that will explore the evolving field of genetic testing as it relates to identifying “silent” genetic carriers and allowing these carriers to determine appropriate options for family planning and health management. The panelists will discuss risk factors among Jewish populations, Jewish ethics about our obligation to stay healthy, and the bioethics of testing.
You’ll also learn how UJA is continuing to respond to evolving needs during the pandemic.
This program is intended as an educational tool for participants. UJA-Federation neither warrants nor represents that the seminars will provide all relevant information concerning the subjects that are addressed, or that the information provided will apply to or be appropriate for all participants. UJA-Federation assumes no liability for the information that is provided. UJA-Federation urges each participant, where necessary, to consult with appropriate professionals to review their own specific needs and requirements.
Lee is director of Venture Investments with Leaps by Bayer, where he aims to contribute to new biotechnologies that enable patients and communities to live healthier lives. Prior to joining Leaps, Lee was entrepreneur-in-residence with RA Capital and founder of Enlight Bio, a biotech focused on genetic disease. Previously, Lee worked in corporate development for Moderna Therapeutics, leading and supporting transactions, financings, and partnerships to develop novel mRNA therapeutics and vaccines. He is a genetic disease patient himself and is the founder of the Institute for Genetic Disease Prevention. He has written on innovation and ethics for Wired, Slate, Tablet, Neo.Life, and STAT News, and also sits on the boards of directors of several biotech companies. Lee earned his J.D. and M.B.A. from Columbia University, where he lectures on topics in biotechnology, and graduated with honors from Dartmouth College with an A.B. in religion.
Emily Goldberg is a genetic counselor for the JScreen program. She received her bachelor’s degrees in biology and psychology from Brandeis University and a master’s degree from the Joan H. Marks Graduate Program in Human Genetics at Sarah Lawrence College. She has been certified by the American Board of Genetic Counseling since 2011. Before joining JScreen, she worked as a genetic counselor at Montefiore Medical Center in the Bronx, specializing in prenatal and cancer genetics. Her professional interests include education, teaching, and mentoring genetic counseling students. She serves as an instructor at the Albert Einstein College of Medicine and adjunct faculty at Sarah Lawrence College where she teaches embryology and reproductive genetics.
Paul Root Wolpe, Ph.D., is the Raymond F. Schinazi Distinguished Research Chair in Jewish Bioethics, professor of medicine, pediatrics, psychiatry, neuroscience, and sociology, and the director of the Center for Ethics at Emory University. Dr. Wolpe served for 17 years as the bioethicist for the National Aeronautics and Space Administration (NASA). Dr. Wolpe publishes widely in sociology, medicine, and ethics, and his work focuses on the social, religious, ethical, and ideological impact of medicine and technology on the human condition. Dr. Wolpe also speaks internationally on topics in the field of Jewish thought. In May 2019, Dr. Wolpe was the commencement speaker and received an honorary degree at the graduation ceremonies of American Jewish University. He was a founder of the Academic Coalition for Jewish Bioethics and bioethics advisor to JScreen, the program to promote preconception genetic carrier screening among Jews. He also works in interfaith ethics, having recently met with the Dalai Lama in Dharamshala, India, to explore links between Jewish and Western ethics and the Dalai Lama’s “secular ethics.” Dr. Wolpe was a major contributor to a guide to Jewish end-of-life issues, Behoref Hayamim: In the Winter of Life.
Nicole Schreiber Agus, Ph.D.